SPRY Stock Analysis: Buy, Sell, or Hold?
SPRY - ARS Pharmaceuticals, Inc. Common Stock
$10.54
0.26 (2.53%)
▲
5d:
+8.66%
30d:
+32.75%
90d:
+39.79%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SPRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SPRY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SPRY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SPRY is currently trading at $10.54, which is considered extended relative to its 30-day fair value range of $8.18 to $9.91.
Technical Outlook: Technically, SPRY is showing sideways momentum. Immediate support is located at $9.05, while resistance sits at $10.87.
Market Sentiment: SPRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.80 (+173.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SPRY is showing sideways momentum. Immediate support is located at $9.05, while resistance sits at $10.87.
Market Sentiment: SPRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.80 (+173.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.18 -
$9.91
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 173.2% below Wall St target ($28.80)
Trading Range Analysis
30-Day Trading Range
$8.18 -
$9.91
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.05
Resistance Level
$10.87
Current Trend
Sideways
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.01
Wall Street Target
$28.80
(+173.2%)
Revenue Growth (YoY)
184.5%
Profit Margin
-200.0%
Share & Embed Analysis
Last updated: June 24, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:54 PM
Data refreshes hourly during market hours. Next update: 6:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
